Podcasts about prasad

In this episode, the hosts unpack the controversial exit of Vinay Prasad from the FDA and what it reveals about fractures inside the MAHA coalition and the broader Trump-era health policy landscape. They examine the disputes surrounding rare-disease drug approvals—particularly Huntington's gene therapy—alongside ongoing battles over COVID vaccines, regulatory standards, and public trust in federal health agencies. The discussion also explores how political alliances, pandemic-era commentary, and conflicts with patient advocacy groups ultimately contributed to Prasad's downfall and what it may signal for the future of vaccine policy and biomedical regulation in the U.S. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

Mere Gurudev Ka Prasad Tumhe Dena Chahta Hun : Pujya Sant Shri Asharamji Bapu Satsang

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the US Food and Drug Administration's Center for Biologics Evaluation and Research after the departure of Director Vinay Prasad (:32), including similarities between the center's leadership issues and the staffing problems in the Harry Potter saga's Hogwarts School of Witchcraft and Wizardry (7:48), as well as the potential policy implications (10:11). They also discuss the contributions of the agency's Real-Time Oncology Review (RTOR) pilot program to the quick reviews of two Commissioner's National Priority Voucher (CNPV) awardees (17:19). More On These Topics From The Pink Sheet US FDA's Vinay Prasad, Controversial CBER Director, Leaving In April: https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fdas-vinay-prasad-controversial-cber-director-leaving-in-april-DJO7ACE73RCNTLZKQWCN2S26LM/ US FDA's CNPV Approvals Ride RTOR Pilot's Coattails: https://insights.citeline.com/pink-sheet/pathways-and-standards/review-pathways/us-fdas-cnpv-approvals-ride-rtor-pilots-coattails-3HEGU5MDWJEG7OYHSZQR6TE5NM/

Mere Gurudev Ka Prasad Tumhe Dena Chahta Hun : Pujya Sant Shri Asharamji Bapu Satsang

Mere Gurudev Ka Prasad Tumhe Dena Chahta Hun : Pujya Sant Shri Asharamji Bapu Satsang

After Friday's news that Center for Biologics Evaluation & Research Chief Vinay Prasad will leave the FDA—again—at the end of April, stocks for several rare disease drug developers popped. UniQure, in particular, was up 51% in premarket trading on Monday. Prasad in a meeting last Thursday with select journalists called the biotech's Huntington's treatment AMT-130 a “failed” therapy, according to STAT News. Shares of Replimune and REGENXBIO—which have suffered rejections during the past year—also rose.One person who is not impressed with the plethora of rare disease drug rejections of late—H.C. Wainwright said in a note Tuesday that there have been at least five cell and gene therapies they believe could have been approved under prior FDA officials—is Wisconsin Senator Ron Johnson. Tuesday, Bloomberg News reported that Johnson has launched an investigation into these recent denials.Johnson called the FDA's request that uniQure conduct a sham surgery-controlled trial of AMT-130 “bureaucratic idiocy,” according to the publication. Meanwhile, uniQure and the FDA appear to be on different pages regarding the design of this prospective trial, with uniQure Chief Medical Officer Walid Abi-Saab referring to a 10-12 hour surgery during which [burr] holes would be drilled in patients' skulls and Prasad claiming on a media call last week that it would require only “one to three nicks in the scalp.”In other news, no episode of The Weekly would be complete without our weekly weight loss segment. Roche and Zealand Pharma's amylin analog fell short of Eli Lilly's rival candidate eloralintide; AbbVie reported what analysts called “competitive” results, with its amylin analog eliciting nearly 10% weight loss at 13 weeks in a Phase 1 trial; and Regeneron touted a much-needed Phase 3 win for Hansoh-partnered dual GLP-1/GIPR agonist olatorepatide in China. Beyond data, Novo Nordisk and Hims & Hers are together again, with Novo striking a deal to sell its injectable and oral GLP-1 medicines through the telehealth provider.Elsewhere on the business side of biopharma, experts are reporting a cut-throat atmosphere behind doors on the M&A front as the supply of companies available to buy dwindles.

Let's know what you liked and learnt! In this episode, Swami is in conversation with Professor T Prasad of IIM Bombay also known as ‘Mandi' Sir. Prof Prasad challenges the conventional model of higher education and argues that real learning happens not through lectures and exams, but through action, experimentation, and value creation. Drawing from decades of teaching experience, he explains how students can move from passive learning to entrepreneurial thinking by engaging directly with markets, customers, and real-world problems. He shares the philosophy behind his “Mandi” approach to learning, where students are encouraged to start companies, test ideas, sell products, and learn from failures while still in college. By connecting classroom knowledge with practical experimentation, he believes education can shift its focus from producing job seekers to nurturing self-reliant creators and job givers.⭐ 5 Key Takeaways1. Learning Happens Through ActionTrue understanding comes when students apply ideas in the real world, experiment with them, and create value rather than simply studying theory.2. The Market is the Best ClassroomWhen students interact with real customers and markets, they naturally learn concepts like pricing, positioning, and value creation that textbooks struggle to teach.3. Education Should Create Job CreatorsThe goal of higher education should not be only to produce employees but to nurture individuals who can build enterprises and create opportunities for others.4. Assignments Should Connect Across DisciplinesInstead of fragmented coursework, learning becomes powerful when assignments across subjects combine to build a real venture or project.5. Startups Can Be a Powerful Learning ToolBy encouraging students to start companies during their education, institutions can create a practical environment where entrepreneurship, leadership, and resilience are learned firsthand.  ⏱️ Timestamps00:03:13 — “Education Must Move From Pedagogy to Self-Driven Learning”00:06:17 — “The Question Is Not the Top 1% — It's the Other 99%”00:09:26 — “Learning Is Not Listening — Learning Is Selling”00:17:14 — “The Market Teaches What the Classroom Cannot”00:25:41 — “From Information to Value Creation — That Is the Real Exam”00:31:48 — “Our Education System Produces Employees, Not Creators”00:35:20 — “Startups Should Be a Part of Education”00:37:41 — “Entrepreneurship Should Be Designed, Not Left to Chance”00:39:17 — “Truth, Self-Reliance, and Non-Violence Define Success”00:40:04 — “Don't Become Another Brick in the Wall”00:41:03 — “Gandhi, Ambedkar, and Visvesvaraya Still Teach Us Today”#entrepreneurship, #educationreform, #studentstartups, #experientiallearning, #highereducation, #startupindia, #entrepreneurialmindset, #learningbydoing, #futureofeducation, #contrarianthinking, #iimbombay, #ContraMindsPodcast, #mandisirThis episode was made possible by the great folks at https://goaffortless.ai.⁠Effortless⁠ has been designed to be user-friendly, aiding you in your journey to streamline financial tasks. Experience the convenience of achieving e-Invoicing and

The second ousting of Vinay Prasad from FDA in the past eight months won't lead to major changes at the agency, other than selecting a successor tasked with keeping FDA out of the news ahead of the coming midterm elections. On the latest BioCentury This Week podcast, Washington editor Steve Usdin lays out why the former CBER director was pushed out at FDA and what's next for the agency following his departure.BioCentury's editors also discuss the next wave of therapies for idiopathic pulmonary fibrosis, including whether new candidates might go beyond slowing disease to halt or even reverse progression, the biological complexity that makes fibrosis so challenging, and what the 20-plus Phase II programs could teach the field about fibrosis biology.Also up for discussion were recent clinical wins — as well as more complicated readouts — from psychedelic therapies; plus the latest data updates from obesity treatments, with a focus on amylin agonists.View full story: https://www.biocentury.com/article/658698#FDA #IdiopathicPulmonaryFibrosis #PsychedelicTherapies #ObesityDrugs #AmylinAgonists00:00 - Introduction01:56 - Prasad's Departure15:27 - Fibrosis Therapies23:35 - Psychedelics Clinical Catalysts28:24 - Obesity UpdatesTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of significant events and trends shaping the industry landscape, offering insight into the dynamic interplay between scientific innovation, regulatory challenges, and strategic growth.Starting with the recent departure of Vinay Prasad from the U.S. Food and Drug Administration, particularly from his role as director of the Center for Biologics Evaluation and Research (CBER). Prasad's tenure, though brief, left an indelible mark characterized by controversy and debate over regulatory decisions. His leadership coincided with significant advancements in biologics and gene editing technologies, like CRISPR, highlighting the complexities in balancing innovation with safety standards. Under Prasad's guidance, the FDA faced challenges in navigating these rapid advancements while maintaining rigorous oversight to ensure that new therapies are both effective and safe for public use. Prasad's resignation signals potential shifts in regulatory philosophy at CBER. The biotech industry is watching closely to see how new leadership will influence ongoing and future evaluations of biologics. The change presents an opportunity to reassess how regulatory bodies can better adapt to scientific advancements while ensuring that patient safety remains paramount. The issues faced during Prasad's tenure underscore the need for transparent decision-making and open communication with stakeholders, which are vital for maintaining trust in regulatory processes.Meanwhile, Pfizer has made a strategic entry into the Chinese obesity market with the approval of a GLP-1 drug developed alongside Sciwind Biosciences. This approval represents not only a significant step for Pfizer but also underscores a broader global focus on obesity management. The efficacy of GLP-1 receptor agonists in weight regulation has opened up new market opportunities, highlighting the growing importance of metabolic health solutions in addressing public health challenges.In other news, Johnson & Johnson's Tecvayli-Darzalex combination therapy has received its third national priority recognition from the FDA for treating multiple myeloma. This recognition reflects promising Phase 3 trial results and underscores the critical role of innovative combination therapies in improving outcomes for complex hematologic malignancies. The success of such therapies illustrates how targeted approaches can significantly enhance treatment efficacy and patient quality of life.Strategic acquisitions continue to reshape industry dynamics. Servier's $2.5 billion acquisition of Day One Biopharmaceuticals aims to strengthen its rare cancer portfolio, including a promising glioma drug, Ojemda. This move highlights Servier's commitment to addressing unmet needs in pediatric oncology and rare diseases, emphasizing a broader industry trend towards focusing on niche therapeutic areas with high potential impact.Regulatory activities are gaining momentum as well, with the FDA set to end a nine-month hiatus in advisory committee meetings by reviewing AstraZeneca's oral selective estrogen receptor degrader Truqa. As AstraZeneca seeks to enhance its oncology pipeline, this review signals ongoing innovation in hormone-based cancer therapies and reflects a renewed emphasis on bringing novel treatments to market efficiently.Additionally, Glenmark Pharmaceuticals has achieved a significant milestone with FDA approval for its generic version of GSK's asthma inhaler Flovent. This development exemplifies efforts to improve access to respiratory treatments by providing cost-effective alternatives to branded medications, potentially reducing healthcare costs while enhancing patient access.On an international scale, Taiwan has announced a substantial investment plan aimed at bolstering its drugSupport the show

Hormones influence every system in the body, from mood and metabolism to sleep, fertility, and the transitions of midlife. In this episode, I'm joined by Vaidya Princy Prasad of Kerala Ayurveda Academy to explore hormone regulation through the classical lens of Ayurveda. Rather than viewing hormones in isolation, we discuss how endocrine balance reflects the state of the doshas, agni, the nervous system, and overall resilience, especially in today's high-stress world. Vaidya Princy shares practical wisdom on building awareness of hormonal fluctuations, supporting the body through stress and burnout, and navigating perimenopause with steadiness and nourishment. In This Episode, We Explore: Why hormone regulation is such a timely focus in modern life How chronic stress and burnout disrupt hormonal balance The relationship between hormones and Vata, Pitta, and Kapha How to observe and track your own hormonal patterns Managing the transition of perimenopause through Ayurveda Ayurvedic herbs that support hormonal health This conversation offers a grounded, holistic perspective on restoring balance and working with your body's natural rhythms rather than against them. Episode Sponsor: This episode is supported by Kerala Ayurveda Academy and Wellness Center and their online store at Kerala Ayurveda Store. If you're looking for high-quality, traditionally prepared Ayurvedic herbal formulas, their products are crafted according to classical Ayurvedic principles and designed to support balance at every stage of life. Check out Kerala Ayurveda Academy here. https://www.keralaayurveda.us/courses/ And as a listener of the podcast, you can receive 10% off your order by using the coupon code Welcome10 at checkout. Visit keralaayurveda.store https://keralaayurveda.store/ Check out Colette's online services:  Online Consultations https://www.elementshealingandwellbeing.com/consultations Group Digestive Reset Cleanse - April 17th, 2026 https://www.elementshealingandwellbeing.com/group-cleanse Private Digestive Reset Cleanse https://www.elementshealingandwellbeing.com/digestive-reset-cleanse Online Daily Habits for Holistic Health Program https://www.elementshealingandwellbeing.com/daily-habits Reset-Restore-Renew Program https://www.elementshealingandwellbeing.com/reset-restore-renew Have questions on Colette's online services? Book a FREE 15 min Services Enquiry Call here. https://www.elementshealingandwellbeing.com/consultations Do I have an accumulation of ama/toxins in my body? Take this quiz to find out https://www.elementshealingandwellbeing.com/resources Stay connected on the Elements social media: Instagram - https://www.instagram.com/elementsofayurvedapodcast/ Facebook - https://www.facebook.com/elementshealingandwellbeing Thank you for listening! If this episode supported you, please consider leaving a review and if you think this information would be helpful to family or friends, please share this episode so we can spread this wisdom of Ayurveda.  Stay tuned and stay aligned with the Elements of Ayurveda Podcast. Thanks for listening!

In The Doom Loop: Why the World Economic Order Is Spiraling into Disorder, Eswar Prasad argues that we are caught in a destructive feedback loop between economics, domestic politics, and geopolitics.Prasad is a professor of Trade Policy and Economics at Cornell University, as well as a Senior Fellow at the Brookings Institution. In his new book, he explores how globalization, international institutions, the rise of “middle power” countries, and technological innovations had the potential to promote shared prosperity—but instead are driving global instability.In his conversation with Nikolaus Lang, global leader of the BCG Henderson Institute, he discusses the breakdown of the rule-based system, implications for trade policy in Europe and elsewhere, and the role AI plays in driving global instability.Key topics discussed: 01:20 | The doom loop driving global instability06:41 | The positive aspects of globalization and middle powers12:02 | Implications for European trade policy15:51 | The breakdown of the rule-based system18:36 | The role of AI and other technologies in the doom loop23:57 | Reasons for remaining optimisticAdditional inspirations from Eswar Prasad:The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance (Belknap Press: An Imprint of Harvard University Press, 2023)

Across more than three decades, UNSW Professor Deo Prasad has shaped the national and global conversation on low carbon living through research, education, policy leadership, and industry collaboration. From pioneering sustainability education in the southern hemisphere to leading Australia's largest built-environment research collaboration through the CRC for Low Carbon Living, his impact spans academia, government, industry, and generations of practitioners worldwide.He talks about his life's work so far, the value of teaching, the importance of building partnerships and how improving sustainability in the built environment is for the benefit of humanity as a whole.

Hon. Ram Prasad Bhandari, the Acting Election Commissioner at the Election Commission Nepal, overseeing 2026 electoral administration and safeguarding transparent democratic processes.

Yoga today is widely understood as a physical practice centered around flexibility and postures. However, its original intent goes far beyond the body. In this episode, we discuss how yoga is not an activity performed for an hour a day, but a lifelong process of refining awareness and transforming the way we perceive ourselves and the world. We examine why suffering has traditionally been the starting point for yogic enquiry, how identity and conditioning shape our experience of reality, and why true yoga involves freeing ourselves from deeply rooted mental patterns rather than simply improving physical capability.Episode Highlights: Why yoga was never meant to be limited to physical posturesThe true goal of yoga: moksha and the removal of sufferingWhy suffering and crisis often initiate deeper spiritual enquiryHow identity itself becomes a source of sufferingThe original definition of asana, according to PatanjaliThe importance of relaxing effort and cultivating awarenessHow yoga transforms personality, perception, and life experienceEpisode Timestamps:00:00 – 05:00: Yoga is more than a physical practice05:00 – 10:00: Yoga as a path, not an activity10:00 – 15:00: The deeper goal of yoga: removal of suffering15:00 – 20:00: Why a crisis often becomes the doorway to yoga20:00 – 25:00: How the mind shapes your entire experience of life25:00 – 30:00: Moksha, desire, and freedom from mental bondage30:00 – 35:00: Chitta vritti and breaking free from conditioning35:00 – 40:00: The illusion of identity and the source of psychological suffering40:00 – 45:00: Spiritual identity and the subtle ego trap45:00 – 50:00: The true meaning of asana according to Patanjali50:00 – 55:00: Effortlessness and the transition into deeper states of awareness55:00 – 60:00: Yoga as a complete system for inner transformationAbout Prasad Rangnekar:Prasad Rangnekar is an internationally respected yoga teacher known for his deep study and teaching of traditional yoga philosophy, especially the Patanjali Yoga Sutras. His work focuses on restoring the original intent of yoga as a path of inner transformation rather than merely a physical practice.About Dr Vignesh Devraj Dr Vignesh Devraj is a fourth-generation Ayurvedic physician and the founder of Sitaram Retreat, Kerala, a space for authentic healing. He is a committed practitioner and researcher of Panchakarma.If you are interested in doing a one-on-one Ayurvedic consultation with Dr Vignesh Devraj please find the details in this link: https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-istIf you are economically challenged, please use the form provided to request a free Ayurvedic consultation here. (or copy paste this in your browser: https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform )BALANCING THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE Vata is responsible for Prana - the life energy, the nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery. Watch my practical inputs that can be integrated into our life at https://vigneshdevraj.com/balancing-the-mighty-vata/ For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com Instagram - @sitarambeachretreat | @vigneshdevrajTwitter - @VigneshDevrajWe truly hope you are enjoying our content. Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support.Disclaimer: - We strongly do not recommend using the content of these episodes as medical advice for any medical conditions.

On this week's episode, Eric Schmidt, Paul Matteis, Sam Fazeli, Graig Suvannavejh, and Luba Greenwood kick off with a discussion on the surge in out licensing deals and growing drug development momentum in China -- a trend they expect will continue. The conversation then shifts to market sentiment, touching on biotech outlook and M&A. in policy news, the group highlights that the FDA reversed its refusal to file a letter for Moderna's flu vaccine after President Trump met with Dr. Marty Makary. They also discuss the FDA's recent regulatory unpredictability, particularly in vaccines and rare diseases. Next, the co-hosts highlight Denali Therapeutics' upcoming PDUFA date for its Hunter syndrome therapy as another test of the FDA's flexibility. The group notes the agency's paper published in NEJM announcing approval of certain drugs based on a single clinical trial, with some viewing it positively for biotech innovation while others caution it may be meaningless, especially with leadership changes. The co-hosts close the discussion on regulatory news by reflecting on positives that have emerged during the Dr. Makary/Dr. Prasad era. In company news, the co-hosts discuss an analysis on the Keytruda patent landscape J&J's investment in a new cell therapy manufacturing plant and data updates from Roche in kidney disease and Compass Pathways' latest psilocybin results. *This episode aired on February 20, 2026.

In this episode, we dive deep into one of Ayurveda's most fundamental yet misunderstood concepts of Agni. Often translated simply as “digestive fire,” Agni is far more than digestion. It is the body's intelligence to transform food into energy, nutrients into tissues, experiences into learning, and stress into resilience. When this ability weakens, stagnation begins. And stagnation, Ayurveda says, is the starting point of disease.Episode Highlights:Why Agni is considered the essence of lifeHow digestion, immunity, and clarity are all expressions of AgniThe difference between Ama (toxins), Ojas (resilience), and Kapha How does lifestyle shape Agni far more than medicinesWhy are autoimmune diseases not randomSrotas: The intelligent functional pathwaysTimestamps: 00:00 – 05:30: What Truly Governs Health?05:30 – 11:00: What Is Agni Beyond “Digestive Fire”?11:00 – 16:30: Levels of Agni in the Body: From Digestion to Tissue Formation16:30 – 21:30: How to Assess Your Agni?21:30 – 26:30: Agni Beyond the Gut: Mind, Vision, Skin & Metabolism26:30 – 35:30: Strengthening Agni the Right Way35:30 – 41:00: Ancient Bodies in a World of Excess41:00 – 46:30: Mental Stress & Agni Breakdown46:30 – 52:00: Pratyaparadha: When Intellect Turns Against Health52:00 – 57:30: Agni, Ojas & Manas: The Triangle That Runs the Body57:30 – 1:00:00: Autoimmunity Through an Ayurvedic Lens1:00:00 – 1:05:30: Srotas: Rethinking Disease Pathways1:05:30 – 1:11:00: Structural vs Functional Srotas1:11:00 – 1:16:30: How the Body Decides What You Become1:16:30 – 1:21:30: Agni, Dhatu Agni & Why the First Conversion Matters Most1:21:30 – 1:27:00: Can Biomarkers Measure Agni? 1:27:00 – 1:29:30:Treating the Person, Not the ReportAbout Dr Vaidya M PrasadDr. Prasad M, a postgraduate in Ayurveda, has been practicing Ayurveda since 1996. He is working as the Principal and Medical Superintendent of Ashtamgam Ayurveda Chikitsalayam & Vidyapeedham, Vavanoor, Palakkad District, Kerala. He has been doing research-oriented work on the care of autistic children since 2002, which has highlighted him as a pioneer in the ayurvedic system to work with autistic children.About Dr Vignesh Devraj Dr Vignesh Devraj is a fourth-generation Ayurvedic physician and the founder of Sitaram Retreat, Kerala, a space for authentic healing. He is a committed practitioner and researcher of Panchakarma.If you are interested in doing a one-on-one Ayurvedic consultation with Dr Vignesh Devraj please find the details in this link: https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-istIf you are economically challenged, please use the form provided to request a free Ayurvedic consultation here. (or copy paste this in your browser: https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform )BALANCING THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE Vata is responsible for Prana - the life energy, the nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery. Watch my practical inputs that can be integrated into our life at https://vigneshdevraj.com/balancing-the-mighty-vata/ For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com Instagram - @sitarambeachretreat | @vigneshdevrajTwitter - @VigneshDevrajWe truly hope you are enjoying our content. Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support.Disclaimer: - We strongly do not recommend using the content of these episodes as medical advice for any medical conditions.

Last week, the FDA declined to review Moderna's mRNA-based flu vaccine, with Center for Biologics Evaluation and Research Director Vinay Prasad himself signing the refuse-to-file (RTF) letter. Prasad said Moderna's comparator group “does notreflect the best-available standard of care,” while Moderna pushed back, saying CBER had previously found a standard-dose flu shot to be an “acceptable” comparator. Despite the shocking turn of events, HHS backed Prasad, saying Moderna didn't “follow very clear FDA guidance from 2024.”Regardless of the reasons, the development imperilsModerna's breakeven plans, affecting not just the company's investigational flu vaccine but also a flu-COVID combo shot and other parts of the company's pipeline. And for the broader industry, it highlights the regulatory uncertainty that persists into 2026, even as other countries move full speed ahead with novel modalities.That regulatory uncertainty extended this week to DiscMedicine, whose rare disease drug bitopertin was rejectedby the FDA. The company tried to convince investors that its planned Phase 3 trial would pave the way toward a refiling, but analysts raised concerns that the study was developed with oldFDA leadership. Disc's situation also raises questions about the FDA's Commissioner's National Priority Voucher, which bitopertin had received.Meanwhile, Compass Pathways dropped long-awaited data from two Phase 3 trials of its psilocybin-based COMP360, showing strong durability data that “clearly met the Street's bar for success,” according to Stifel analysts. The company plans to complete a rolling new drug application by the end of the year.Finally, the CDC has been left leaderless, again, with the departure of Jim O'Neill, who had been servingas acting director after the ouster of Susan Monarez last summer. And Sanofi's Paul Hudson was removed as CEO last week. He'll be replaced by Merck KGaA's Belén Garijo, who becomes just the second woman in charge of a Big pharmacompany.

Ainz "Brainz" Prasad is an internationally recognized and award winning music producer. He has worked with musical legends such as Jamie Foxx, Kenny "Babyface" Edmonds, Pink, Snoop Dogg and Miley Cyrus. In addition, Ainz has added film score and music supervision on various film, television and commercial projects to his long list of talents. Instagram @brainzmusicwww.brainzmusic.com

The Truth About Swasthani Brata. In this insightful podcast episode, Hari Prasad Sodari, a renowned Nepali Religious History author, explains the deep spiritual, cultural, and philosophical meaning of Swasthani Katha and Swasthani Brata. The discussion explores the importance of Swasthani, why Swasthani is celebrated every year, and whether this sacred Hindu tradition is followed only by Nepalis or has broader roots in Hindu mythology. Hari Prasad Sodari also challenges modern ideas by discussing how Hindu mythology vs evolution theory presents alternative perspectives through ancient scriptures. The podcast breaks down the steps of celebrating Swasthani Brata, the significance of Salinadhi, and clarifies common questions such as whether reading the first page of the Swasthani book is compulsory. Listeners will gain a clear summary of the Swasthani book, understand the purpose of studying Swasthani every year, and learn why Swasthani puja is more than just rituals—it is a spiritual discipline rooted in Nepali Hindu traditions and ancient Hindu scriptures. This episode is essential for anyone interested in Nepali religious history, Hindu spiritual practices, and the true meaning behind Swasthani Katha. GET CONNECTED WITH Hari Prasad Sodari: Facebook - https://www.facebook.com/hariprasad.sodari/  

Prithvi Narayan Shah & Nepal Unification Explained | Hari Prasad Sodari. Hari Prasad Sodari, a renowned Nepali author and social media personality from Kathmandu, joins this in-depth podcast to discuss the life, vision, and legacy of Prithvi Narayan Shah, the founder of modern Nepal. This episode examines the unification journey of Nepal, the strategic brilliance behind the Gorkha Kingdom, and the historical significance of Divyopadesh in shaping Nepal's national identity. The conversation delves deep into Nepal's history, including conflicts among writers, debates over Prithvi Narayan Shah's good and bad decisions, and whether the capture of the Kathmandu Valley was a Gorkha victory or a national one. Hari Prasad Sodari explains how Prithvi Narayan Shah understood regional geopolitics involving India and China, when the idea of unification truly began, and how he emerged as the central figure in Nepal's political history. This Nepali history podcast also reflects on lessons modern Nepal can learn from Prithvi Narayan Shah's leadership, discipline, respect for elders, and long-term vision. Whether you are interested in Nepal unification, nationalism, or historical leadership, this episode offers valuable insights grounded in research and storytelling. GET CONNECTED WITH Hari Prasad Sodari: Facebook - https://www.facebook.com/hariprasad.sodari/  

Nepal on the World Boxing Map. Nepali boxing is entering a historic era, and this powerful podcast brings together three of the biggest names driving that change — Lal Prasad Upreti, Chandra Bahadur Thapa, and Sujit Kumar Pun Magar (Jet Boxing). Lal Prasad Upreti gained international recognition at the IBA Men's Elite World Boxing Championships, while Chandra Bahadur Thapa made history as the first Nepali to win a medal at the World Boxing Championships. Guiding this rise is Jet Boxing, an IBA and USA Boxing-certified coach and founder of H2O Athletics, who has shaped Nepal's elite fighters. In this episode, they discuss what it truly takes to compete at the world level in boxing, sharing insights on international tournament experience, Asian amateur boxing standards, and the intense fight camps in Rangasala. The conversation dives into strict training routines, no-holiday policies, mental pressure before fights, and how fighters are selected for global tournaments. They also open up about their personal boxing journeys, family reactions, sacrifices, and what boxing means to them beyond medals. With Mission 2026 in focus, this episode captures the grit, discipline, and vision behind the rapid growth of Nepali boxing on the world stage. A must-watch for boxing fans, athletes, and anyone inspired by Nepal's sporting evolution. GET CONNECTED WITH {guest name}: Lal Prasad Upreti: Instagram - https://www.instagram.com/pradipkazi__/ Facebook - https://www.facebook.com/pradip.upreti.102 TikTok - https://www.tiktok.com/@lalprasadupreti Chandra Bahadur Thapa: Instagram - https://www.instagram.com/boxer_chandra/?g=5 Facebook - https://www.facebook.com/chandra.thapa.magar.116183 TikTok - https://www.tiktok.com/@chandrathapa426 Sujit Kumar Pun Magar (Jet Boxing): Instagram - https://www.instagram.com/p/DSePIuIk27O/?img_index=1 Facebook - https://www.facebook.com/Jetslick/ Threads - https://www.threads.com/@jetboxing Tiktok - https://www.tiktok.com/@jetboxing  

Nepal is home to a rich and diverse range of amphibians and reptiles, yet much of this wildlife remains misunderstood. In this podcast episode, we sit down with Bishal Prasad Neupane, a leading Nepali herpetologist and conservationist, to explore the hidden world of snakes of Nepal, frogs, crocodiles, turtles, tortoises, and lizards. Bishal shares how he became interested in reptiles and amphibians, explains the different types of crocodiles in Nepal, and why crocodiles survived even after the extinction of dinosaurs. The conversation dives deep into frog species in Nepal, frog hunting practices, frog dissection in colleges, and ethical concerns around amphibian conservation. We also cover turtles and tortoises in Nepal, the legal aspects of keeping turtles as pets, and the key differences between turtle vs tortoise. A major highlight of this episode is snakes—covering poisonous snakes in Nepal, snake behavior, whether snakes are aggressive, what snakes eat, what anaconda is, and how snake rescue works in Nepal. Most importantly, Bishal explains what to do if a snake bites, how anti venom in Nepal is made, and common myths surrounding snake bites. This episode is essential for anyone interested in wildlife conservation in Nepal, reptile research, snake bite awareness, and understanding Nepal's herpetofauna. GET CONNECTED WITH Bishal Prasad Neupane: Instagram - https://www.instagram.com/bishalneupane0/ YouTube - https://www.youtube.com/@nepalisapien7821/videos  

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

In his weekly clinical update, Dr. Griffin and Vincent Racaniello protest Vinjay Prasad, head of CBER FDA Nov memo stating administration of the COVID-19 vaccine resulted in 10 children's deaths, but are cautiously delighted by the December memo from those in CBER who dispute this data-less claim, how in 31 states pertussis vaccination rates have declined before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, of clinical outcomes of oseltamivir versus baloxavir for treating influenza infection, number deaths associated with COVID-19 hospitalizations and disease associated economic burden, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how the German government is committed to research into long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Industry laments Prasad vaccine memo (Politico) Scoop: FDA vaccine chief's memo cited 10 pediatric Covid-19 vaccine deaths—but the agency's own analysis found 0–7 (Inside Medicine) Whooping cough cases soar as vaccination rates drop (NBC News) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Comparison of clinical outcomes of oseltamivir versus baloxavir in outpatients with influenza: a retrospective cohort analysis (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (CDC:MMWR) Mortality following recovery from COVID-19 hospitalization: A long-term cohort study (International Journal of Infectious Diseases) COVID hospitalization tied to 69% higher risk of death for up to 2 years (CIDRAP) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir (Journal of Medical Economics) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments?(Nature) Reaching out to US house representative Letters read on TWiV 1280 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

In this episode of THE MENTORS RADIO, Host Dan Hesse talks with Dr. Eswar Prasad, a Professor of Economics at Cornell, a senior fellow at Brookings, and the former head of the IMF's China division, to discuss his book The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, which was chosen as a Best Book of the Year by The Economist, The Financial Times, Foreign Affairs, ProMarket, and The Week. In The Future of Money, Dr. Prasad argues that we are at an inflection point where technology is redefining what money is, who issues it, and how it moves—pushing us toward a world with less physical cash, and an ecosystem of fintech and crypto innovations that will reshape everything from household payments to the global monetary order. LISTEN TO the radio broadcast live on iHeart Radio, or to “THE MENTORS RADIO” podcast any time, anywhere, on any podcast platform – subscribe here and don't miss an episode! SHOW NOTES: ESWAR S. PRASAD: BIO: BIO: Eswar S. Prasad BOOKS: The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, by Eswar S. Prasad The Doom Loop: Why the World Economic Order Is Spiraling into Disorder, by Eswar S. Prasad Gaining Currency: The Rise of the Renminbi, by Eswar S. Prasad The Dollar Trap: How the U.S. Dollar TIghtened its Grip on Global Finance, by Eswar S. Prasad WEBSITE: https://www.futureofmoneybook.com/

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research cuts, vaccine policy fights and leadership churn at the FDA, then push the conversation forward into the questions that will shape 2026. The through line is that uncertainty has become an operating environment, and the industry is recalibrating in real time. Fierce Biotech’s Gabrielle Masson, joined by Darren Incorvia, traces how funding decisions can narrow the pipeline years before the consequences are visible. Fierce Pharma’s Fraiser Kansteiner sits down with Angus Liu and Eric Sagonowsky to unpack the new center of gravity inside federal agencies, where vaccine recommendations, review norms and new FDA pilots are colliding with questions about capacity and outside influence. From there, Ben Adams and James Waldron bring the lens to Europe, where Jefferies in London captured a cautiously optimistic market still wrestling with tariffs, pricing pressure and investment hesitation. The episode closes with Fierce Healthcare’s Heather Landi and Paige Minemyer sharing their outlook on 2026, from the fight over ACA subsidies and Medicaid headwinds to the next phase of AI adoption, where the promise is real but the payoff may be slower, messier and more uneven than the hype suggests. To learn more about the topics in this episode: 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation NIH grant cuts have disrupted hundreds of clinical trials, study finds 'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines House passes healthcare affordability bill without subsidy extension AMA: A look at concentration in commercial insurance, MA markets 2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind See omnystudio.com/listener for privacy information.

Eli Lilly is wrapping up 2025 with record-breaking weight loss in a late-stage trial for its triple hormone receptor agonist retatrutide. Results from the Phase III TRIUMPH-4 trial exceeded analyst expectations, leading BMO Capital markets to cleverly dub it “a true TRIUMPH.” Also in the weight loss arena, Zealand Pharma inked a deal with China's OTR Therapeutics worth up to $2.5 billion to collaborate on next-gen drugs for obesity and other metabolic diseases, and Rhythm Pharmaceuticals awaits a Dec. 20 FDA verdict for Imcivree in hypothalamic obesity.   Turning to the FDA, reports broke late last week that the agency was considering slapping a black box label—its strictest warning—on COVID-19 vaccines. Commissioner Marty Makary denied those reports on Monday, stating on Bloomberg TV that the FDA has “no plans” to make such a move. This follows an internal memo from Vinay Prasad leaked over Thanksgiving in which the CBER director claimed that “at least” 10 children have died “because of” COVID-19 vaccines. An internal safety review published last week refuted this conclusion, instead concluding that between zero and seven deaths could be linked to the shots.   Pfizer CEO Albert Bourla, for one, is tired of the recent rhetoric from HHS on vaccines and hopes they are “an anomaly” that will be corrected soon. With strong words about the administration's sentiment on vaccines, Bourla prominsed Pfizer's continued investment in vaccines despite declining revenue. Pfizer this week lowered its 2026 guidance to $62.5 billion in revenue, missing analyst consensus.  The FDA has also granted several approvals in the past week, to Amgen, Milestone Pharmaceuticals and AstraZeneca and Daiichi Sankyo. USAntibiotics also snagged a greenlight, for Augmentin XR, the first approval to be given under the agency's new Commissioner's National Priority Voucher (CNPV) program. Also this week, Johnson & Johnson scored a CNPV ticket—without even having to apply—for its investigational combo of Tecvayli plus Darzalex for relapsed or refractory multiple myeloma after the FDA was impressed by Phase III data.   In ClinicaSpace this week, we highlighted 5 of 2025's Defining Clinical Wins and The 5 Most Painful Clinical Trial Failures of 2025. This past week provided a few more on each front. In the winner's circle, Immunome's desmoid tumor drug and and Kyverna's CAR T for stiff person syndrome both aced pivotal trials, while Sanofi's MS drug tolebrutinib and Gilead and Arcus' TIGIT therapy domvanalimab each failed Phase III tests.   And in BioPharm Executive, we highlight 6 Biotechs That Could Be Big Pharma's Next M&A Target, and more M&A predictions for 2026.  

Why do we even need AI — and why now? Host Nick Schutt sits down with Sunil Prasad, Leidos Principal Solutions Architect and Georgia Tech-trained data scientist, for a sweeping journey through AI's 100-year history — from 1920s conceptual foundations to today's agentic AI — and a candid debate on whether machines will ever climb to the top of the food chain. Key topics: The 5 phases of AI evolution (1920s–2025) From perceptrons to LLMs to agentic workflows Why AI is outsourcing human cognition for the first time since the Industrial Revolution Where AI shines today (predictive analytics, autonomous systems) Where it shouldn't go (parenting, therapy, lethal decisions) If you're wondering whether AI is just hype or the next industrial leap, this episode is for you. Channel: @RobotsandRedTapeAI | Host: Nick Schutt Subscribe for more no-BS conversations on tech, bureaucracy, and the future.

In this inspiring episode, Ambassador Elisha sits down with Dr. Rahul Prasad — scientist, author, global thinker, and humanitarian leader

This episode breaks down a moment most people aren't paying close enough attention to: the quiet collapse of leadership and process inside the FDA. Jonathan Howard and Wendy Orent walk through the sudden resignation of a widely respected career regulator, the internal turmoil left behind, and a leaked memo claiming child deaths from COVID vaccines—released without public data, peer review, or transparent methodology. Rather than debating vaccines in the abstract, the conversation focuses on something more troubling: what happens when regulatory standards erode, scientific disagreement turns political, and decision-making bypasses established safeguards. With career experts stepping away and unvetted claims driving policy discussions, the episode asks whether the FDA can still function as a credible public health authority—and what the consequences may be if it can't. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability.  Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here!  Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci

Howie and Harlan are joined by Sudhakar Nuti to discuss his work improving healthcare for homeless New Yorkers, as a street-medicine doctor and a population-health leader at NYC Health + Hospitals. Harlan reports on a proposed law that would cut off funding for U.S. scientists who collaborate with colleagues in China; Howie provides updates on the measles outbreak and a leaked FDA memo claiming that COVID-19 vaccines have killed 10 children. Show notes: Science Across Borders Subtitle C—SAFE Research Act "U.S. Congress considers sweeping ban on Chinese collaborations" Sudhakar Nuti NYC Health + Hospitals Street Medicine Institute "Health Care beyond Clinic Walls—Sustaining and Scaling Up Street Medicine" NYC Health + Hospitals: Street Health Outreach & Wellness Mobile Units "Graduate and professional students tackle food insecurity" California Depart of Public Health: Xylazine Measles CDC: Measles Cases and Outbreaks "Tracking U.S. Measles Outbreaks" World Health Organization: Weekly Epidemiological Record, 2025, vol. 100, no. 48 "Winning against measles: five charts that tell a remarkable 24-year story" "Measles deaths down 88% since 2000, but cases surge" FDA Leak "Experts say top FDA official's claim that Covid vaccines caused kids' deaths requires more evidence" "FDA's Prasad tells staffers agency plans to get tougher on vaccine regulation, blames child deaths on COVID shots" "Thoughts on Vinay Prasad's Leaked Email" "Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021" "Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review" In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.  

Vinay Prasad's memo, leaked over the weekend, has sent vaccine makers' stocks slipping and experts clamoring for more evidence to support the CBER director's claim that COVID vaccines have led to the deaths of at least 10 children. It's the latest insult to the vaccine sector from the healthcare administration this year, with other challenges coming on the CDC side, where the recently revamped advisory committee is heading into its next meeting with a brand new chair.  Elsewhere at the FDA, newly promoted Center for Drug Evaluation and Research Director Richard Pazdur has filed the paperwork to retire from the agency just weeks after reportedly reluctantly accepting the position.   Meanwhile, the Alzheimer's space is buzzing as the 2025 Clinical Trials on Alzheimer's Disease (CTAD) conference continues in San Diego. Last week saw a mid-stage flop for Johnson & Johnson's anti-tau candidate and the “definitive” failure of Novo's GLP-1 semaglutide—which analysts say may actually help uptake of anti-amyloid therapies from Biogen and Eli Lilly. Meanwhile, Roche announced positive results for its latest antibody, putting the pharma back in the game it had once stepped back from in the tumultuous days of Aduhelm.   In the weight loss space, Novo Nordisk revealed ‘competitive' mid-stage data for its next-gen amycretin, which showed no weight-loss plateau over 36 weeks in patients with type 2 diabetes. Meanwhile, the pricing war for approved and future GLP-1s from Novo and obesity rival Eli Lilly rages on, with Lilly this week announcing another price drop for Zepbound through its LillyDirect self-pay platform.  In BioPharm Executive this week, we review the top venture capital rounds for female-founded biotechs and examine the 2026 biotech market outlook. 

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceutical and biotech sectors are currently experiencing a wave of transformative changes. A significant development is the trade agreement between the United States and the United Kingdom, which excludes medicines from import tariffs. This strategic move, orchestrated by the Trump administration, is set to reduce costs and bolster investments in pharma sectors across both nations. By enhancing market accessibility, it aims to stimulate cross-border investment in pharmaceutical research and production.On the clinical front, Eli Lilly is making headlines by joining Novo Nordisk in reducing self-pay prices for its GLP-1 receptor agonist, Zepbound. This reflects a broader industry trend towards patient-centric pricing models aimed at improving affordability. With healthcare costs on the rise, these measures could ease financial burdens for patients requiring long-term medication regimens.Regulatory updates are also making waves, with the FDA planning stricter vaccine regulations under Dr. Vinay Prasad's leadership at the Center for Biologics Evaluation and Research (CBER). These updates come amid concerns over vaccine safety during COVID-19-related incidents, underscoring a commitment to maintaining public trust in vaccines. Regulatory scrutiny continues as Prasad focuses on COVID-19 vaccine safety in children amid reports linking 10 child deaths to vaccines via VAERS—emphasizing challenges interpreting safety data while highlighting the need for robust methodologies ensuring reliable causality conclusions.In corporate restructuring news, Valneva is streamlining its operations by closing a site and eliminating 30 roles. This move highlights an industry focus on optimizing resources to bolster vaccine development pipelines. Meanwhile, Microsize and Schedio's acquisition of Lonza's Swiss micronization plant underscores ongoing investments in advanced manufacturing technologies critical for high-quality pharmaceuticals.In ophthalmology, Belite Bio is advancing with promising Phase 3 results for tinlarebant in treating Stargardt disease—a rare genetic eye disorder. This success positions Belite to file for FDA approval, potentially expanding treatment options for this underserved patient population. Such advancements in targeted therapies emphasize the need for ongoing research in genetic disorders.Regeneron is betting $150 million on Tessera's gene writing technology targeting alpha-1 antitrypsin deficiency (AATD). This collaboration highlights the industry's growing interest in gene therapy as a frontier for treating rare diseases, marking a shift towards precision medicine where tailored genetic interventions offer hope for previously untreatable conditions. Regeneron's strategic move investing $275 million partnering with Tessera exploring gene editing capabilities—focusing on TSRA-196 targeting the SERPINA1 gene linked to AATD showcases potential advancing therapeutic options for genetic disorders through gene editing technologies offering new disease treatment avenues.AI-driven platforms were spotlighted at RSNA 2025 by industry leaders such as GE Healthcare, Philips, and Siemens. These innovations promise to revolutionize radiological workflows by enhancing diagnostic accuracy and operational efficiency through AI integration. As AI continues to permeate healthcare technologies, its potential to transform diagnostic processes marks a significant leap towards personalized medicine.Akebia Therapeutics' acquisition ofSupport the show

In this episode, Brandon sits down with Seema Prasad, the visionary owner of Miel, one of Nashville's most beloved farm-driven restaurants. Seema is known for her intentional, soulful approach to hospitality, her deep relationships with local farmers and producers, and her commitment to creating a dining experience rooted in integrity, sustainability, and joy.Together, Seema and Brandon dive into:Her collaborative relationship with Chef Jason IaconaHow they approach menu development, seasonality, storytelling, and experimentationWhy honoring ingredients — and where they come from — is at the heart of every plate at MielHow Seema builds long-standing partnerships with local farmersThe responsibility independent restaurants carry in preserving food culture and supporting regional agricultureWhy “slow hospitality” matters now more than everSeema's philosophy on nurturing her teamCreating a workplace grounded in respect, curiosity, and shared valuesWhat she believes the next generation of restaurateurs needs to hearHow the restaurant continues to evolveExciting projects and ideas on the horizonSeema's hopes for Nashville's restaurant scene in the coming yearsThis episode is a beautiful, thoughtful conversation with one of Nashville's most respected independent operators. If you care about farm-to-table dining, restaurant leadership, or the craft of hospitality, you're going to love this one.Listen now and share with someone who loves the stories behind great restaurants.

"Hum ek qabristan mein baithe hain... Aur qaatil hamare saath hi rehte hain."The horrifying discovery in the temple has shattered the last illusion of safety. The investigation is over; the fight for survival has begun.Trapped within the suffocating walls of the Chandra Raajbaari, Vyom and Sudhanshu are no longer guests—they are prisoners in a house that is preparing for a feast. As the dark night of Amavasya descends, the polite veneer of the Prasad family crumbles, revealing a sinister intent that has been rotting beneath the surface for centuries.With time running out, their only hope lies in deciphering a madman's diary and finding a silent child who hums a melody not of this world. But the key to the mystery—a blackened Mangalsutra buried in the dirt—might just be the most dangerous thing of all.What waits in the tunnels beneath the mansion? Can Vyom's logic stand against an evil that defies all reason?The ritual is about to begin.Support the Creator: Leave a contribution via UPI - ankansharmishthabose@sbiCredits:Written By: Ankan Sharmishtha BoseProduced By: Ankan Sharmishtha Bose and Garima PugaliaOriginal Background Score: Manov Bhowmick and Abhishek NandaSound Design: Manov Bhowmick and Abhishek NandaProject Managed By: Tarun Gupta and Mryunmayee PadmagirwarJoin this channel to get access to exclusive perks:https://www.youtube.com/channel/UCn9JS93zsaUDaUDq7aofhNQ/joinInstagram- https://www.instagram.com/bhayoriginals/[Bhay Originals, Hindi Horror Stories, Tathyanweshi Vyom Bagchi, Ankan Sharmishtha Bose, Indian Horror Podcast, Vyom Bagchi Detective, Cursed Mangalsutra Story, Haunted Haveli, Hindi Audio Drama, Mystery Thriller Hindi, Bengali Folk Horror, Horror Story 2025, Detective Horror Story, Dark Rituals, Mool Maa, Chandra Raajbaari, New Hindi Horror Story, Bhay Podcast, Suspense Thriller Hindi, Supernatural Investigation, Mangalsutra Episode 2]

This episode dives deep into the escalating chaos inside the FDA as leaders, scientists, and biotech insiders publicly revolt against the agency's current direction. Hosts Jonathan and Wendy break down the explosive STAT News investigations revealing mass resignations, internal fear, political interference, and allegations of mismanagement under V. Prasad's leadership. The episode unpacks the controversial rejection of a promising Huntington's disease gene therapy, accusations of shifting scientific standards, and the quiet but aggressive attempt by FDA officials — including Tracy Beth Høeg — to restrict access to COVID vaccines for young men. From vaccine policy upheavals to political pressure from the RFK Jr. administration, this conversation exposes the "soap opera" unraveling inside the nation's most important medical regulatory body — and what the turmoil could mean for patients, public trust, and the future of science in America. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

1984, New Delhi/ Curated by Irfan/BECOME A PATRON : Work on Listen with Irfan takes time, money and hard work to produce. As of now it is being done voluntarily with the family, friends and listeners who came forward for hand holding from its inception.  If you like the Podcasts, admire it, and benefit from its content, please consider awarding us an honorarium to make the future of this Podcast Channel robust and assured.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠यहाँ आपको मिलती हैं वो दुर्लभ आवाज़ें खुद बोलती, गाती और बहस करती। मनोहर श्याम जोशी, कमलेश्वर, कृष्णा सोबती, बी वी कारंत, शमशेर बहादुर सिंह, बलराज साहनी, अज्ञेय, रसूलन बाई, निर्मल वर्मा, मंगलेश डबराल, राजेंद्र यादव, चंद्रकांत देवताले, भवानी प्रसाद मिश्र, इस्मत चुग़ताई, सत्यदेव दुबे, त्रिलोचन, अमरीश पुरी, इब्राहीम अल्क़ाज़ी, मोहन उप्रेती, गोरख पांडेय, नैना देवी, वीरेन डंगवाल, मन्नू भंडारी, भीष्म साहनी, देवकी नंदन पांडे आदि के अलावा अनगिनत भारतीय और विदेशी समकालीन विचारक, कलाकार, लेखक, कवि और सांस्कृतिक लड़ाके। किताबों पर चर्चा के पॉडकास्ट, संगीत, फिल्म रिव्यू और स्ट्रीट रिकॉर्डिंग्स का एकमात्र पॉडकास्ट मंच। Details to support this Podcast Channel i.e. ⁠⁠⁠⁠⁠⁠⁠⁠⁠Listen with Irfan⁠⁠⁠⁠⁠⁠⁠⁠⁠ :-Bank Name: State Bank Of IndiaName: SYED MOHD IRFANAccount No:32188719331Branch: State Bank of India, Vaishali Sec 4, GhaziabadIFSC–SBIN0013238UPI/Gpay ID irfan.rstv-2@oksbiCover: Irfan

Prof. Bishnu Prasad Basel on Youth Protest, Politics & Nepal's Future. In this thought-provoking podcast, Prof. Bishnu Prasad Basel, Adjunct Professor of Sociology at Tribhuvan University, joins us for a deep conversation about the state of Nepal's politics, the rise of youth protests, and the future of socialism and democracy in the country. From the Gen Z protest movements to the struggles within Nepal's political parties, Prof. Basel explains how social structures, economic inequality, and ideological confusion are shaping modern Nepal. He also discusses why democracy exists in theory but not within political parties, what role socialism and capitalism play in Nepal's development, and how the country can create a more accountable political system. We dive into the history of Nepal's unification by Prithvi Narayan Shah, the role of caste in politics, and the urgent need for civic education and youth engagement. This episode offers deep insight into why protests repeat, how new political parties struggle to emerge, and what Nepal must do to achieve true democratic reform. Whether you're a student, political observer, or active citizen, this conversation with Prof. Bishnu Prasad Basel will reshape how you view Nepal's democracy, governance, and political culture. #NepalPolitics #BishnuPrasadBasel #GenZProtest #Socialism #Democracy #PoliticalChange #Nepal #Communism #YouthInPolitics #CapitalismInNepal GET CONNECTED WITH Prof. Bishnu Prasad Basel: Email - baselbishnu@gmail.com Twitter - https://x.com/BishnuBasel99    

In this episode of The ModGolf Podcast host Colin Weston sits down with Alex Prasad, the CEO of V1 Sports, a company that has been a cornerstone of golf technology for over three decades. Alex shares the journey of V1 Sports from its origins in pioneering video analysis to its current position as an innovator leveraging AI and ground force sensors. We dive deep into the pivotal "come-to-Jesus" moment that forced the company to re-evaluate its path, the cultural shift to a data-driven mindset, and how they are now using their new AI tool, "V1CTOR," to solve the biggest pain points for golf instructors - time and student engagement. This is a masterclass in business transformation, product-market fit, and building a platform that creates a true win-win-win for the company, the coach, and the golfer. During this episode you will discover these inspiring takeaways: Embrace the "Why" Behind the Data Learn how V1 Sports moved beyond assumptions by relentlessly asking "how do we know?" This shift to a data-validated culture gave them the courage to innovate confidently and build products based on proven user needs, not just gut feelings. Solve the Real Problem, Not the Stated One Discover how Alex and his team decoded the common complaint from pros that they "don't have enough time." They uncovered the deeper issue of seasonality and student re-engagement, leading to AI-driven solutions that automate relationship-building. Trust is Built by Providing Value First Hear how V1 Sports flipped the script on traditional coaching models. By using AI to facilitate a "Quick Fix"—a free, personalized piece of feedback—they create a gateway to trust between a golfer and a pro, proving value before a transaction ever occurs. https://media24.fireside.fm/file/fireside-uploads-2024/images/1/1ea879c1-a4a2-4e10-bea4-e5d8368a3c7a/2parL16M.jpg Episode Chapters: (00:00) Introduction (01:29) The Power of Invitation: Alex's First Golf Experience (04:02) The Origin Story of V1 Sports (06:55) The Innovator's Dilemma: The Inflection Point for V1 (12:18) The Hard Work of Product Validation: Talking to Customers (16:11) The V1 Product Suite and the Introduction of "V1CTOR" AI (22:14) Building Trust in a Digital World (27:40) The V1 Business Model: A Two-Sided, Curated Marketplace (31:51) The Hardware Game: Ground Pressure Sensors and the Unseeable Data (34:33) Expanding to Other Sports? The Power of Focus (38:44) The Entrepreneurial Marathon: Lessons from Endurance Sports (43:30) How to Connect with Alex Prasad and V1 Sports Book referenced during our converation: The Innovator's Dilemma (https://www.amazon.ca/Innovators-Dilemma-New-Foreword-Technologies/dp/1647826764/ref=asc_df_1647826764) by Clayton M. Christensen Quotable Moments from Alex: On Challenging Assumptions: "Intuition can tell you where to look, but the data is going to validate or invalidate that's the right place to press." On Understanding Customer Needs: "What you learn is, customers can tell you their pain points, they can tell you their aspirations, but what they can't tell you is the solution... It's not their job. That's ours." On the Core Philosophy of V1's AI companion, V1CTOR: "The best way to build trust between a random person on the internet and a golf instructor is to show some value first." Are you more of a watcher than a listener? Then enjoy our video with Alex on The ModGolf YouTube channel (https://youtu.be/YBxBsVuRti8). Click on this link (https://youtu.be/TDyhOE2DEuo) or the image below. https://media24.fireside.fm/file/fireside-uploads-2024/images/1/1ea879c1-a4a2-4e10-bea4-e5d8368a3c7a/2DQnq5hM.jpg (https://youtu.be/TDyhOE2DEuo) Want to connect with Alex? Check out his bio page to make that happen! Alex Prasad's bio page >> https://modgolf.fireside.fm/guests/alex-prasad Visit the V1 Sports website (https://v1sports.com/) to learn more and to download the V1 Golf App in the Apple App Store or Google Play Store. https://media24.fireside.fm/file/fireside-uploads-2024/images/1/1ea879c1-a4a2-4e10-bea4-e5d8368a3c7a/fC_NoWtr.png (https://v1sports.com/) Join our mission to make golf more innovative, inclusive and fun... and WIN some awesome golf gear! As the creator and host of The ModGolf Podcast and YouTube channel I've been telling golf entrepreneurship and innovation stories since May 2017 and I love the community of ModGolfers that we are building. I'm excited to announce that I just launched our ModGolf Patreon page to bring together our close-knit community of golf-loving people! As my Patron you will get access to exclusive live monthly interactive shows where you can participate, ask-me-anything video events, bonus content, golf product discounts and entry in members-only ModGolf Giveaway contests. I'm offering two monthly membership tiers at $5 and $15 USD, but you can also join for free. Your subscription will ensure that The ModGolf Podcast continues to grow so that I can focus on creating unique and impactful stories that support and celebrate the future of golf. Click to join >> https://patreon.com/Modgolf I look forward to seeing you during an upcoming live show!... Colin https://files.fireside.fm/file/fireside-uploads/images/1/1ea879c1-a4a2-4e10-bea4-e5d8368a3c7a/q_IZwlpO.jpg (https://patreon.com/Modgolf) Special Guest: Alex Prasad - CEO at V1 Sports.

In this gripping Halloween episode marking the second anniversary of We Want Them Infected, hosts Dr. Jonathan Howard and Dr. Wendy Orange confront the chilling reality of America under "Trump II." They dissect the collapse of public health, the weaponization of medicine, and the transformation of science into "Trump-Based Medicine"—a term Jonathan coins to describe physicians parroting political dogma over data.   The duo highlights interviews and statements by Vinay Prasad, Marty Makary, Jay Bhattacharya, and Martin Kulldorff, who now echo President Trump's pseudoscientific vaccine directives—like splitting the MMR shot and delaying Hepatitis B vaccines. They warn that this alignment with anti-vaccine figures such as RFK Jr. and Andrew Wakefield marks a dangerous regression that could undo decades of medical progress.   They also expose turmoil within the FDA, where Prasad's leadership has allegedly created a culture of fear, and discuss the growing exodus of scientists from federal health agencies. From declining measles vaccination rates to government loyalty tests, Howard and Orange paint a harrowing portrait of a nation sliding into scientific authoritarianism.   The episode closes with their sobering realization: despite years of warning, even they underestimated how dark things could get.         Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

“The line between AI workload and non-AI workload is getting blurrier by the day.” Prasad Kalyanaraman, VP of AWS Infrastructure Services, talks with Anurag Rana, Senior Technology Analyst at Bloomberg Intelligence, about what actually changes as AI scales. Prasad lays out the realities behind “AI data centers”: denser accelerators, non-blocking training networks, and modular in-chip liquid cooling. Underneath, the data-center basic priorities hold -— security as job zero, plus availability, performance, and cost. He also explains why clusters must be fungible between training and inference so accelerators and power never sit idle, and how AWS retrofits existing regions rather than treating AI as a separate build. 

In today's episode, we explore one of Ayurveda's most fascinating diagnostic tools: the tongue. The art of tongue analysis, or Jivha Pariksha, allows practitioners to see what's happening in the body and mind before a single word is spoken, revealing the subtle imbalances, stagnation and vitality reflected on the surface of the tongue according to ancient texts.The Charaka and Sushruta Samhitas, the color coating, texture, and shape of the tongue, provide profound clues about an individual's health. In Ayurveda, the tongue is seen not merely as a muscle for taste and speech, but as a map linked to multiple organs and systems in the body. Key diagnostic insights include: detection of doshic imbalances, accumulation of toxins in the system, status of metabolic health, and signs of organ dysfunction.Joining us today is Dr. Rama Prasad. A distinguished Ayurvedic practitioner and educator with over three decades of clinical experience. Dr. Prasad is internationally recognized for his pioneering work in therapeutic fasting mind, body medicine, and holistic health assessment. He has been instrumental in introducing Ayurveda to Western health professionals through international conferences.Training programs and coaching. Currently, Dr. Rama leads innovative projects at Vaidyagrama Ayurveda Healing Village, where he focuses on online education, app development, and specialized wellness programs for a range of health conditions. His mission is to bridge the timeless principles of Ayurveda with modern healthcare, empowering both practitioners and clients to deepen their understanding of the body's innate intelligence.Today we dive into how the tongue serves as a mirror to the organs, what specific colors, textures, and shapes reveal about the doshas, and how Jivha Pariksha can help us detect and balance as long before they manifest as disease. So take a deep breath, settle in and prepare to see your health through a whole new lens: one that begins right at the tip of your tongue.Send us a textFor 20% off Kerala Ayurveda products, use code OjasOasis at checkoutFor 20% off GarryNSun products, use code OJASOASIS20 at checkout Support the showTo learn more about working with us, please visit www.OjasOasis.com Connect with us @ojasoasis on Instagram

Please visit Jasravee at ⁠⁠https://jasravee.com/⁠⁠Email Jasravee at jasravee@gmail.com

In this episode of The Pastoral Thoughts Podcast, Pastor Jack Young sits down with Vara Prasad, a missionary to India whose life and ministry reflect remarkable courage and faith. Born into a pastor's home, Vara grew up watching his father plant churches and preach the gospel amid growing persecution. Though trained as a computer programmer, Vara eventually surrendered to God's call to preach after a life-changing illness. Today, he ministers in a nation where sharing the gospel can cost you your freedom—or your life.Hear Vara's firsthand account of imprisonment, harassment by authorities, and the boldness of believers who continue to worship despite opposition. His story is a powerful reminder that the gospel still advances—even under fire.

Dancing Elephant was founded by Saira Malhotra, an internationally trained chef and TV personality, and Chandni Prasad, an Ayurvedic wellness advocate with deep roots in public service and global policy.Rooted in tradition but reimagined for today, Dancing Elephant brings this beloved Indian staple to the American market with a fresh, vibrant perspective. what we chat about:The roots of kitchari + why it's such comforting meal in South Asian homesHow Dancing Elephant reimagined kitchari for today's busy, wellness-conscious eaters without losing its soulSaira & Chandni's third-culture experienceIG dancingelephant_ayurveda | thedancingelephant.comFind Me:IG + TikTok citrusdiaries.studiocitrusdiaries.com | hello@citrusdiaries.comCreate your ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ today! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#madeonzencastr

Join Craig Fuller and freight tech veteran Prasad Gollapalli (Founder of Trucker Tools and Queued) as they dive deep into the brutal competition and market dynamics shaking up the load board ecosystem. #FreightTech #LoadBoards #Trucking #DAT #Highway #TruckStop #Logistics #SupplyChain #FreightRecession #Entrepreneurship Learn more about your ad choices. Visit megaphone.fm/adchoices

Chef Prasad Chirnomula is an award-winning chef and a two time Honoree of the popular James Beard Foundation. Chef Prasad owns and operates Chef Prasad in New Canaan, CT and Gourmet United in Easton, CT.Episode Sponsors:The Amber Room Colonnade⁠⁠⁠⁠⁠https://www.theamberroom.net/⁠⁠⁠⁠⁠Affinity Esports⁠⁠⁠⁠https://www.affinityesports.gg/⁠⁠⁠⁠Negative Kitty⁠⁠⁠⁠https://linktr.ee/negative_kitty⁠

Colette is joined by Ayurvedic doctor and educator Vaidya Princy Prasad for a deeper exploration of Agni, the inner fire that fuels far more than just digestion. While Agni is often associated with metabolism, its influence extends into immunity, hormonal balance, emotional clarity, and overall vitality. In this conversation, they discuss the following: What Agni really is and why it's central to vibrant health and ojas The different types of Agni and various levels of action Signs of optimal (sama) Agni and what happens when it's imbalanced The types of impaired Agni: Vishama, Tikshna and Manda How Agni influences key hormones  Practical Ayurvedic tips to kindle and sustain a balanced Agni Why seasonal cleansing is vital for reseting Agni * Thanks to Kerala Ayurveda Academy for sponsoring this episode. Explore upcoming trainings at Kerala Ayurveda Academy. Use code ELEMENTS100 to save $100 on your enrollment. Learn more at keralaayurveda.us/courses. * Click here to register for the discounted Digestive Reset Cleanse starting October 3rd, 2025 * Visit Colette's website www.elementshealingandwellbeing.com  Online consultations & Gift Vouchers Next discounted Group Cleanse starts October 3rd, 2025 Private at-home Digestive Reset Cleanse tailored to you Educational programs - Daily Habits for Holistic Health Reset-Restore-Renew Program Have questions before you book? Book a FREE 15 min online Services Enquiry Call * Join the Elements of Ayurveda Community! * Stay connected on the Elements Instagram and Facebook pages. * Enjoy discounts on your favourite Ayurvedic products: Banyan Botanicals - enter discount code EOA15 at checkout for 15% off your first purchase.** Divya's  - enter discount code ELEMENTSOFAYURVEDA15 at checkout for 15% off your first purchase.** Kerala Ayurveda - enter discount code ELEMENTS15 to receive 15% off your first purchase.** LifeSpa - Save $10 on a $50 or more one-time purchase with the code elements10.  **Shipping available within the U.S. only. * Thank you for listening! If this episode supported you, please consider leaving a review and if you think this information would be helpful to family or friends, please share this episode so we can spread this wisdom of Ayurveda.  Stay tuned and stay aligned with the Elements of Ayurveda Podcast.      

Today we discuss sex and vaccines, reality and renegades. First: men can no longer compete in women's sports—from Trump's Executive Order, to the NCAA's response, to William “Lia” Thomas having his records rescinded at Penn, reality is prevailing. Other evidence includes the UK Supreme Court declaring that “man” and “woman” refer to biological reality; and the U.S. Supreme Court writing an opinion that forcing LGBTQ+ books on children in public elementary schools is unconstitutional. Men cannot magically turn into women, nor boys into girls, no matter what they believe or are told. Then: from the ACIP (Advisory Committee on Immunization Practices) to Vinay Prasad's latest presentation at the FDA: the federal government is being populated by a combination of true renegades and middle ground scramblers who are dressed like renegades. A good toolkit for understanding how to make sense of the claims being made is necessary, and we all should be rooting for the renegades to win.*****Our sponsors:CrowdHealth: Pay for healthcare with crowdfunding instead of insurance. It's way better. Use code DarkHorse at JoinCrowdHealth.com to get 1st 3 months for $99/month.ARMRA Colostrum is an ancient bioactive whole food that can strengthen your immune system. Go to http://www.tryarmra.com/DARKHORSE to get 15% off your first order.Helix: Excellent, sleep-enhancing, American-made mattresses. Go to www.HelixSleep.com/DarkHorse for 27% Off - an offer exclusive for listeners of DarkHorse!*****Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.comHeather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.comOur book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned)Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org*****Mentioned in this episode:Trump's EO: https://www.whitehouse.gov/presidential-actions/2025/02/keeping-men-out-of-womens-sports/Paula Scanlan speaks about men in women's sports:https://x.com/xx_xyathletics/status/1940381615131332719U.K. Supreme Court: https://www.supremecourt.uk/cases/uksc-2024-0042The Lancet – sex isn't binary! https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00834-7/fulltextU.S. Supreme Court – Mahmoud vs Taylor: https://www.supremecourt.gov/opinions/24pdf/24-297_4f14.pdfWilliam Thomas in the record books: https://www.outkick.com/sports/lia-thomas-upenn-womens-swimming-record-books-updated-acknowledges-transgender-swimmer-noteRFK Jr on Tucker: https://www.youtube.com/watch?v=w_fzlwxJZAAACIP committee with Robert Malone and Retsef Levi: https://x.com/janjekielek/status/1939482343313453423Prasad on myocarditis: https://x.com/US_FDA/status/1940111214497210425Prasad makes full professor: https://x.com/bretweinstein/status/1554849287300792320Earlier clips of ZDogg and Prasad and Makary: https://x.com/alexandrosm/status/1574530850565558272Support the show